Oleoylcarnitine, a metabolite that accumulates following suppression of fatty acid β-oxidation, has been shown to promote hepatocarcinogenesis through STAT3 activation in the context of obesity-driven HCC [45]. This evidence concerns the gene STAT3 and hepatocellular carcinoma.